Abstract
The adult central nervous system (CNS) contains a population of neural stem cells, yet unlike many other tissues, has a very limited capacity for self-repair. Promoting tissue repair and functional recovery following CNS injury or disease is a high priority as there are currently no effective treatments towards this end for the treatment of disorders such as stroke, traumatic brain injury and spinal cord injury. Recent advances in stem cell biology have offered a number of enticing potential avenues and we will discuss these possibilities along with the associated challenges as they pertain to stroke. We will consider exogenous therapies involving the transplantation of adult stem cells, and the mobilization of endogenous stem cells, as well as drug delivery and tissue engineering strategies that enhance and complement the cell based strategies.
Keywords: Adult stem cells, neural regeneration, biomaterials, tissue engineering, drug delivery systems, stroke, central nervous system, traumatic brain injury, spinal cord injury, Surgery
Current Stem Cell Research & Therapy
Title: Adult Stem Cells and Bioengineering Strategies for the Treatment of Cerebral Ischemic Stroke
Volume: 6 Issue: 3
Author(s): Fenggang Yu and Cindi M. Morshead
Affiliation:
Keywords: Adult stem cells, neural regeneration, biomaterials, tissue engineering, drug delivery systems, stroke, central nervous system, traumatic brain injury, spinal cord injury, Surgery
Abstract: The adult central nervous system (CNS) contains a population of neural stem cells, yet unlike many other tissues, has a very limited capacity for self-repair. Promoting tissue repair and functional recovery following CNS injury or disease is a high priority as there are currently no effective treatments towards this end for the treatment of disorders such as stroke, traumatic brain injury and spinal cord injury. Recent advances in stem cell biology have offered a number of enticing potential avenues and we will discuss these possibilities along with the associated challenges as they pertain to stroke. We will consider exogenous therapies involving the transplantation of adult stem cells, and the mobilization of endogenous stem cells, as well as drug delivery and tissue engineering strategies that enhance and complement the cell based strategies.
Export Options
About this article
Cite this article as:
Yu Fenggang and M. Morshead Cindi, Adult Stem Cells and Bioengineering Strategies for the Treatment of Cerebral Ischemic Stroke, Current Stem Cell Research & Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157488811796575341
DOI https://dx.doi.org/10.2174/157488811796575341 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitric Oxide in the Dorsal Medulla Modulates Excitatory Somatosympathetic Reflexes
Current Cardiology Reviews A Translational View of Peptide Treatment of Neurological Disorders
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current Stem Cell Research & Therapy Epigenetic Drugs for Multiple Sclerosis
Current Neuropharmacology Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions
Current Pharmaceutical Design Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review
Current Stem Cell Research & Therapy Editorial (Thematic Issue: Current Research and Clinical Application of Ultrasound Imaging in Musculoskeletal System)
Current Medical Imaging Neuroimaging of Non-Accidental Injury
Current Pediatric Reviews New Missions for an Old Agent: Granulocyte-Colony Stimulating Factor in the Treatment of Stroke Patients
Current Medicinal Chemistry The Application of Proteomics in Neurology
Current Proteomics Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Neuroprotection by Alpha 2-Adrenergic Agonists in Cerebral Ischemia
Current Neuropharmacology Subject Index to Volume 3
Current Drug Targets - CNS & Neurological Disorders Editorial [Exploring Neural-Immune System Interactions]
Current Immunology Reviews (Discontinued) Evaluation of Pregabalin Therapy in Peripheral Neuropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Marine Food Protection in Testicular Damages Caused by Diabetes Mellitus
Current Diabetes Reviews Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Activities of Venom Proteins and Peptides with Possible Therapeutic Applications from Bees and WASPS
Protein & Peptide Letters A Pivotal Role of the Nrf2 Signaling Pathway in Spinal Cord Injury: A Prospective Therapeutics Study
CNS & Neurological Disorders - Drug Targets Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs
Current Cancer Drug Targets